The price, which is confidential and was negotiated for a maximum of 300 huge number of doses, is a little lower than the $19.50 a photo the United States agreed to purchase a first shipment of hundred million doses of the same vaccine, in line with what Reuters claimed in November.
The EU file dated Nov. 18 was circulated internally after the EU announced its supply offer with Pfizer and the German partner BioNTech of its on Nov. eleven.
The EU drug regulator is actually expected to determine on Monday on acceptance for the Pfizer vaccine after the shot was authorised in a few countries, including Britain and also the United States.
On Thursday Belgian say secretary for the spending budget Eva De Bleeker released on Twitter a table with costs Belgium would shell out pharmaceutical companies for the COVID 19 vaccines of theirs. She retracted the piece of writing shortly after publishing.
In that dining room table the Pfizer vaccine was suggested as costing Belgium twelve euros ($14.6) a dose, top many to believe that was the full price agreed with the EU.
Various other vaccines in the table were also shown with rates lower compared to prices disclosed by EU sources.
“There is , naturally, a total fee along with a cost after delivery,” an EU official involved in talks with vaccine makers told Reuters when directed to clarify the difference between the Belgian and EU prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker said Belgium’s budgeted prices were still partial.
Underneath EU advance purchase deals for COVID 19 vaccines, the bloc believes upfront payments with businesses to secure doses before they are approved. After approvals, EU governments can pay the rest to get reserved doses.
The EU hasn’t revealed the upfront payment agreed with Pfizer.
But, it stated in October that it paid about one billion euros in downpayments to AstraZeneca, Sanofi and Johnson & Johnson for their shots, with an additional 1.45 billion euros budgeted for initial payments to Pfizer BioNTech, Curevac and Moderna.
It’s since agreed source deals with all six corporations and is negotiating a seventh agreement with Novavax.